2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow EDP-239: new trials by email Literature Review of EDP-239 trials Research Report on EDP-239
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Two-way Interaction Between Alisporivir and EDP239 DEB025, EDP239 - Hepatitis C Virus | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 42 | 2014-08-01 | 2015-01-09 |
| Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects EDP239, Placebo - Hepatitis C | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 28 | 2013-06-01 | 2016-01-29 |
Hepatitis C (2) · Communicable Diseases (1) · Infections (1)
Enanta Pharmaceuticals, Inc (2)
Germany (2) · United States (1)